In yet another pharmaceutical deal, Endo International plc (Nasdaq: ENDP) is buying Dava Pharmaceuticals for $575 million in cash.

Dava, headquartered in Fort Lee, New Jersey, specializes in marketed, pre-launch and generic pharmaceuticals, including Amoxicillin capsules and Penicillin.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.